ERS – 9-13 September 2017 Milan

[vc_row][vc_column width=”1/1″][vc_column_text]OncoArendi will present a poster on The Therapeutic Efficacy of OAT-889 (DualAMCase/CHIT1 Inhibitor) in Comparison to Montelukast in HDM-induced Model of Chronic Airway Inflammation in Mice, on Wednesday 13th, 10th at 8:30 AM. (link: Poster OAT-889 ERS 2017)

[/vc_column_text][/vc_column][/vc_row]